| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3244ba8390b1f290f4ba36389c82488b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 |
| filingDate |
1993-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2004-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41ad4ba478b51a9702c05454c6e52138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2491b8cae4307ed278d491e941934d46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d7ba75433299c16bcd26c2938a2824b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5883048a562abc066332a2f8270ee4bb |
| publicationDate |
2004-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2065313-T5 |
| titleOfInvention |
TABLET WITH IMPROVED BIODISPONIBILITY CONTAINING DICHLOROMETILENDIFOSFONICO ACID AS ACTIVE SUBSTANCE. |
| abstract |
The invention relates to tablets with improved bioavailability OF THE ACTIVE SUBSTANCE dichloromethylene diphosphonic acid of a salt physiologically tolerable and a content of microcrystalline cellulose as auxiliary substance pharmaceuticals, packaged THIS MEDICINE CONTAINING THESE TABLETS, USE OF THE ACTIVE SUBSTANCE dichloromethylene diphosphonic acid JOINTLY WITH MICROCRYSTALLINE CELL FOR THE ELABORATION OF A TABLET WITH IMPROVED BIODISPONIBILITY AND A PROCEDURE FOR THE ELABORATION OF THE TABLET. |
| priorityDate |
1993-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |